About

Mr. Lloyd has founded and managed several high-tech companies in the medical device, medical service and drug delivery areas. Currently, he is Founder and Principal in several companies developing drug delivery systems and non-invasive measurement and monitoring. Previously, he was Founder of Alere Medical (monitoring patients at home for heart failure and other chronic diseases – sold to Inverness, now Alere, in 2007); Founder, President and Chairman of Aradigm (which developed, manufactured and licensed devices and systems for aerosol drug delivery for systemic effect, including insulin – IPO in 1996); Founder and President of Nellcor Incorporated (anesthesia monitoring, developer of the pulse oximeter – IPO in 1987, now part of Covidien); owned patents in digital hearing aid (licensed to ReSound and sold to Siemens in 1995); and Founder and President of Humphrey Instruments (ophthalmic instruments – sold to Smith Kline in 1980, now part of Zeiss). Mr. Lloyd has served on the public boards of Nellcor, Aradigm, Aspect Medical, and Molecular Dynamics and is a director, investor and advisor to several medical device and drug delivery companies. He presently serves as on the advisory committee to the dean of the College of Engineering at the University of California, Berkeley. Mr. Lloyd has a BSME from University of California, Berkeley and holds 30 US Patents.

Mr. Coleridge has served as the CEO of ViOptix, Inc for the past 5 years. A highly experienced medical technology executive, Mr. Coleridge’s recent experience includes serving as Co-Founder of Apple Medical (sold to Cooper Surgical), Executive Vice President, FEI Women’s Health (sold to Barr Laboratoriess, now Teva Pharmaceuticals), developer of the only non-hormonal female contraceptive, Mr. Coleridge has spent more than 20 years starting or being part of the senior management team for several early-stage life science companies, including Kingston Diagnostics, developer of the first whole blood cholesterol test (Licensed to Warner Lambert/Pfizer) and CEO of Synthon Chiragenics (sold to Avecia). After the sale of FEI to Barr Laboratories in 2005, Mr. Coleridge joined Morningside Technology Advisory, LLC. He is also a member of the Board of Directors of Excera Orthopedics and Humanzyme, Inc.

Mr. Shearer is a leading investment banking and venture capital professional and has a strong focus on healthcare and medical technology. He specializes in advising emerging growth and middle market healthcare companies in raising commercialization stage capital and completing strategic alliance and merger and acquisition transactions. Mr. Shearer is Founder and Principal of Channel Medical Partners, a venture firm focused on commercialization stage investing in the medical technology industry, and Managing Director of Healthios Capital Markets, LLC, an investment banking boutique with exclusive focus on emerging growth healthcare companies. Mr. Shearer has previously held senior positions with a number of major investment banking firms including Vector Securities International, Bankers Trust Company and Kidder, Peabody & Co. Inc. Mr. Shearer is on the Board of Cylex Inc. and is a former Board member of Venetec International Inc. and Novare Surgical Systems. Inc.

Ms. Parr has over 25 years’ experience in venture and private equity investing and fund raising and corporate finance working for Canadian Medical Discoveries Fund, Canada Pension Plan (CPP), TD Capital, Ontario Municipal Employees Retirement System (OMERS), Canadian Corporate Funding Ltd, Trivest Insurance Network (a Trilon company) and Continental Illinois Bank. She currently manages the GrowthWorks Canadian Fund through Crimson Capital. She headed the Direct Equity group for four of her twelve years at OMERS making direct debt, venture capital and private equity investments. She has served on 30 boards of private companies on behalf of institutional investors and is a Director of CellAegis Devices, an early stage medical device company she helped found. As President of Crimson Capital, an OSC registered Exempt Market Dealer, she has worked with a number of technology and growth companies to build their businesses and has been involved in numerous equity capital raises and securing of government grants and loans. She also holds an MBA from York University and Masters and Honors degrees from the University of Toronto in International Relations